Exact Mass: 686.542637
Exact Mass Matches: 686.542637
Found 318 metabolites which its exact mass value is equals to given mass value 686.542637,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
SM(d17:2(4E,8Z)/16:0)
C38H75N2O6P (686.5362460000001)
Sphingomyelin (d17:2(4E,8Z)/16:0) or SM(d17:2(4E,8Z)/16:0) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. SM(d17:2(4E,8Z)/16:0) consists of a 4E,8Z-heptadecasphingdienine backbone and a palmitic acid chain. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SM has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition, it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2, an enzyme that breaks down sphingomyelin into ceramide, has been found to localize exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme sphingomyelinase, which causes the accumulation of sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.
DG(20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)
DG(20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/20:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))
DG(20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/20:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)
DG(20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/20:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))
DG(20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/20:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)
DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/20:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))
DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/20:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)
DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/20:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))
DG(20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/20:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)
DG(20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/20:0/0:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))
DG(20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/20:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)
DG(20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/20:0/0:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))
DG(20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/20:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)
DG(i-20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-20:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))
DG(i-20:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-20:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)
DG(i-20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-20:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))
DG(i-20:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-20:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)
DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-20:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))
DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-20:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)
DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-20:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))
DG(i-20:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-20:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)
DG(i-20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-20:0/0:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))
DG(i-20:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-20:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)
DG(i-20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-20:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-20:0/0:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-20:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-20:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))
DG(i-20:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-20:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-20:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Trisanhydrobacterioruberin
PE-Cer(d14:1/22:1(13Z))
C38H75N2O6P (686.5362460000001)
PE-Cer(d14:2(4E,6E)/22:0)
C38H75N2O6P (686.5362460000001)
PE-Cer(d16:2(4E,6E)/20:0)
C38H75N2O6P (686.5362460000001)
CerPE 36:2;O2
C38H75N2O6P (686.5362460000001)
[(E)-3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-2-(heptanoylamino)-3-hydroxyhexacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-2-(hexanoylamino)-3-hydroxyheptacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-2-acetamido-3-hydroxyhentriaconta-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-3-hydroxy-2-(nonanoylamino)tetracosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-2-(butanoylamino)-3-hydroxynonacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-3-hydroxy-2-(pentanoylamino)octacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-3-hydroxy-2-(octanoylamino)pentacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-3-hydroxy-2-(propanoylamino)triaconta-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-2-(henicosanoylamino)-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-3-hydroxy-2-(icosanoylamino)trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]tridecyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyheptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyheptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-3-hydroxy-2-(undecanoylamino)docosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-2-(decanoylamino)-3-hydroxytricosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
2,3-di(octanoyloxy)propyl (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate
2,3-di(nonanoyloxy)propyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
(2-dodecanoyloxy-3-octanoyloxypropyl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate
[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-octanoyloxypropan-2-yl] (Z)-hexadec-9-enoate
(3-nonanoyloxy-2-pentadecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-octanoyloxypropan-2-yl] hexadecanoate
(3-octanoyloxy-2-tetradecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
(3-nonanoyloxy-2-undecanoyloxypropyl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
(3-nonanoyloxy-2-tridecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
(2-decanoyloxy-3-octanoyloxypropyl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
2,3-di(decanoyloxy)propyl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
(3-decanoyloxy-2-dodecanoyloxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
(2-tridecanoyloxy-3-undecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(3-decanoyloxy-2-tetradecanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
2,3-di(undecanoyloxy)propyl (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
2,3-di(dodecanoyloxy)propyl (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-2-(hexadecanoylamino)-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]nonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-3-hydroxy-2-(octadecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)nonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-2-(heptadecanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-3-hydroxy-2-(nonadecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-3-hydroxy-2-(tridecanoylamino)icosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-2-(dodecanoylamino)-3-hydroxyhenicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)octadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[1-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] tetradecanoate
[3-dodecanoyloxy-2-[(Z)-dodec-5-enoyl]oxypropyl] (9Z,11Z,13Z)-hexadeca-9,11,13-trienoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate
[1-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropan-2-yl] tetradecanoate
[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-tridecanoyloxypropyl] (Z)-pentadec-9-enoate
[3-tridecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (5Z,8Z,11Z)-tetradeca-5,8,11-trienoate
[2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] hexadecanoate
[1-[(Z)-dodec-5-enoyl]oxy-3-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[3-[(Z)-dodec-5-enoyl]oxy-2-tridecanoyloxypropyl] (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate
[(E)-2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxyheptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
2,3-di(dodecanoyloxy)propyl (7Z,9Z,11Z,13Z)-hexadeca-7,9,11,13-tetraenoate
2,3-bis[[(6Z,9Z)-dodeca-6,9-dienoyl]oxy]propyl hexadecanoate
[2-[[(4Z,7Z)-hexadeca-4,7-dienoyl]amino]-3-hydroxyheptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[3-[(Z)-dodec-5-enoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate
[3-dodecanoyloxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (6Z,9Z,12Z)-pentadeca-6,9,12-trienoate
[3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] pentadecanoate
[1-[(Z)-dodec-5-enoyl]oxy-3-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] tetradecanoate
[(E)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
2,3-bis[[(Z)-dodec-5-enoyl]oxy]propyl (4Z,7Z)-hexadeca-4,7-dienoate
[3-hydroxy-2-[[(10Z,12Z)-octadeca-10,12-dienoyl]amino]pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-dodecanoyloxypropyl] (4Z,7Z)-hexadeca-4,7-dienoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-tridecanoyloxypropyl] (9Z,12Z)-pentadeca-9,12-dienoate
[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-[(Z)-dodec-5-enoyl]oxypropyl] (Z)-hexadec-7-enoate
2,3-bis[[(Z)-tridec-8-enoyl]oxy]propyl (7Z,9Z)-tetradeca-7,9-dienoate
[1-dodecanoyloxy-3-[(5Z,8Z,11Z)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[3-dodecanoyloxy-2-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxypropyl] (Z)-hexadec-7-enoate
[3-dodecanoyloxy-2-[(7Z,9Z)-tetradeca-7,9-dienoyl]oxypropyl] (7Z,9Z)-tetradeca-7,9-dienoate
[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-[(Z)-tridec-8-enoyl]oxypropyl] (Z)-pentadec-9-enoate
[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyhenicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R,4E,8E)-2-(hexadecanoylamino)-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R,4E,8E)-3-hydroxy-2-(octadecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyheptadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R)-3-hydroxy-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)nonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R,4E,8E)-2-(heptadecanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R,4E,8E)-3-hydroxy-2-(nonadecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R,4E,8E)-3-hydroxy-2-(tridecanoylamino)icosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R,4E,6E)-3-hydroxy-2-(octadecanoylamino)pentadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2R,3S,4E,8E)-2-(dodecanoylamino)-3-hydroxyhenicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R,4E,8E)-3-hydroxy-2-(pentadecanoylamino)octadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E,2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxyheptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E,2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]pentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R,4E,6E)-2-(heptadecanoylamino)-3-hydroxyhexadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(E,2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyhexadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R,4E,14E)-3-hydroxy-2-(pentadecanoylamino)octadeca-4,14-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
[(2S,3R,4E,6E)-3-hydroxy-2-(nonadecanoylamino)tetradeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C38H75N2O6P (686.5362460000001)
ceramide phosphoethanolamine (36:2)
C38H75N2O6P (686.5362460000001)
A ceramide phosphoethanolamine in which the sphingoid base and acyl group contains a total of 36 carbon atoms and 2 double bonds.
N-[(13Z)-docosenoyl]-tetradecasphing-4-enine-1-phosphoethanolamine
C38H75N2O6P (686.5362460000001)
A N-acyltetradecasphingosine-1-phosphoethanolamine in which the acyl group specified is (13Z)-docosenoyl.
TG(40:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MGMG(30:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved